Cargando…

Ki67 and P53 Expression in Relation to Clinicopathological Features in Phyllodes Tumour of the Breast

OBJECTIVE: Phyllodes tumour (PT) is a rare fibroepithelial neoplasm of the breast that carries a risk of malignancy. Histopathological examination remains a gold standard for diagnosis. The usage of the immunohistochemical markers of Ki67 and p53 acts as a supplement method, particularly for the mal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Nurul Atiah Mohd, Nasaruddin, Ahmad Fazlin, Mohamed, Syarah Syamimi, Rahman, Wan Faiziah Wan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779430/ https://www.ncbi.nlm.nih.gov/pubmed/32986365 http://dx.doi.org/10.31557/APJCP.2020.21.9.2653

Ejemplares similares

The Enigma of Giant Phyllodes Tumour
por: Gan, Seng Yeong, et al.
Publicado: (2022)

Immunohistochemical expression of Ki-67, p53, and CD10 in phyllodes tumor and their correlation with its histological grade
por: Shubham, Swasti, et al.
Publicado: (2019)

Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas
por: XIAO, LI-JUN, et al.
Publicado: (2013)

Expression and clinicopathological correlation of Ki-67 in gallbladder carcinoma
por: Gupta, Amit, et al.
Publicado: (2021)

Association of Ki-67 With Clinicopathological Factors in Breast Cancer
por: ., Nishit, et al.
Publicado: (2021)

Estrogen Receptor-Negative Breast Ductal Carcinoma: Clinicopathological Features and Mib-1 (Ki-67) Proliferative Index Association
por: MdPaiman, Noorasmaliza, et al.
Publicado: (2014)

PTEN and Ki67 expression is associated with clinicopathologic features of non-small cell lung cancer
por: Ji, Yong, et al.
Publicado: (2014)

Expressions of Topo IIα and Ki67 in breast cancer and its clinicopathologic features and prognosis
por: Sun, Guangyu, et al.
Publicado: (2019)

Clinicopathological Features Associated With the Prognosis of Patients With Adrenal Cortical Carcinoma: Usefulness of the Ki-67 Index
por: Choi, Yun Mi, et al.
Publicado: (2016)

Expression of Cyclooxygenase-2, p53 and Ki-67 in Gastric Cancer
por: Joo, Young-Eun, et al.
Publicado: (2006)

Expression of miR-34a and Ki67 in nasopharyngeal carcinoma and the relationship with clinicopathological features and prognosis
por: Wei, Linqi, et al.
Publicado: (2020)

Immunohistochemical Evaluation of Ki-67 and Comparison with Clinicopathologic Factors in Breast Carcinomas
por: Aman, Nguiessan Alphonse, et al.
Publicado: (2019)

Prognostic and Clinicopathological Value of Ki-67 in Melanoma: A Meta-Analysis
por: Liu, Qixin, et al.
Publicado: (2021)

Significance of p53 and ki-67 expression in prostate cancer
por: Verma, Renuka, et al.
Publicado: (2015)

Association between Ki-67 expression and clinicopathological features in prognosis of breast cancer: A retrospective cohort study
por: Kamranzadeh, Hosein, et al.
Publicado: (2019)

Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast
por: Tsang, Julia Y. S., et al.
Publicado: (2018)

Lung carcinoid tumours: histology and Ki‐67, the eternal rivalry
por: Centonze, Giovanni, et al.
Publicado: (2022)

Cyclooxygenase-2 and Ki67 Expression in Oral Leukoplakia: a Clinicopathological Study
por: Sinanoglu, Alper, et al.
Publicado: (2015)

The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator?
por: Tang, Jingdong, et al.
Publicado: (2018)

Clinicopathological Profile of Primary Hyperparathyroidism with Special Reference to Ki-67 Labelling Index
por: Thanveer, Azhar S., et al.
Publicado: (2023)

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours.
por: Jaros, E., et al.
Publicado: (1992)

Phyllodes tumour of the breast
por: Muttarak, M, et al.
Publicado: (2006)

Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
por: Park, H. R., et al.
Publicado: (1995)

Radiomic prediction models for the level of Ki-67 and p53 in glioma
por: Sun, Xiaojun, et al.
Publicado: (2020)

Immunoexpression of Ki67, p53 and cyclin D1 in osteosarcomas
por: Niculescu, Ştefan Adrian, et al.
Publicado: (2021)

Evaluation of P57, P53 and Ki67 Expression in Meningiomas
por: Küçükosmanoğlu, İlknur, et al.
Publicado: (2022)

Ki-67 expression in luminal type breast cancer and its association with the clinicopathology of the cancer
por: YUAN, PENG, et al.
Publicado: (2016)

A study of Ki-67 expression and its clinicopathological determinants in nondysplastic oral leukoplakia
por: Mondal, Krishnendu, et al.
Publicado: (2016)

An Immunohistochemical Study on Ki-67 Expression in Squamous Cell Carcinomas of Cervix With Clinicopathological Correlation
por: R, Devaki Priyanka, et al.
Publicado: (2023)

Evaluation of Ki-67 expression in feline non-ocular melanocytic tumours
por: Sabattini, Silvia, et al.
Publicado: (2018)

Immunohistochemical Evaluation of p53 and Ki67 Expression in Skin Epithelial Tumors
por: Khodaeiani, Effat, et al.
Publicado: (2013)

General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67
por: Sipos, Tamás-Csaba, et al.
Publicado: (2023)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Ki67 expression in breast cancer: Correlation with prognostic markers and clinicopathological parameters in Saudi patients
por: Elkablawy, Mohamed A., et al.
Publicado: (2016)

Prognostic and clinicopathological value of Ki-67 expression in patients with nasopharyngeal carcinoma: a meta-analysis
por: Shi, Zhaohui, et al.
Publicado: (2020)

Clinicopathological characteristics of peripheral clinical stage IA lung adenocarcinoma with high Ki-67 expression
por: Liu, Zhan, et al.
Publicado: (2021)

Morphological features of 52 cases of breast phyllodes tumours with local recurrence
por: Bi, Jiaxin, et al.
Publicado: (2022)

Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma
por: Song, Jinbo, et al.
Publicado: (2021)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Correlation of Clinicopathological Features of Breast Cancer with Molecular Subtypes Taking Ki-67 into Consideration: Single Institution Experience Over 5 Years
por: PEREIRA, CHIRAG, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_951cq8j4lvamfjeep0o270e3u7